1. Differential impact of the COVID-19 pandemic on laboratory reporting of norovirus and Campylobacter in England: A modelling approach
- Author
-
Roberto Vivancos, Helen E. Clough, Nigel A. Cunliffe, Nikola Ondrikova, Amy Douglas, Lesley Larkin, John P. Harris, and Miren Iturriza-Gomara
- Subjects
RNA viruses ,Viral Diseases ,Research Facilities ,Epidemiology ,Coronaviruses ,medicine.disease_cause ,Pathology and Laboratory Medicine ,COVID-19 Testing ,Medical Conditions ,Pandemic ,Campylobacter Infections ,Medicine and Health Sciences ,Medicine ,Caliciviridae Infections ,Virus Testing ,Multidisciplinary ,Transmission (medicine) ,Campylobacter ,Bacterial Pathogens ,Infectious Diseases ,England ,Medical Microbiology ,Viral Pathogens ,Viruses ,Pathogens ,SARS CoV 2 ,Research Laboratories ,Research Article ,Coronavirus disease 2019 (COVID-19) ,SARS coronavirus ,Infectious Disease Control ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Science ,Disease Surveillance ,Research and Analysis Methods ,Microbiology ,Caliciviruses ,Diagnostic Medicine ,Environmental health ,Humans ,Pandemics ,Microbial Pathogens ,Differential impact ,Biology and life sciences ,Bacteria ,business.industry ,SARS-CoV-2 ,Norovirus ,Organisms ,COVID-19 ,Covid 19 ,Laboratory reporting ,Infectious Disease Surveillance ,business ,Laboratories ,Government Laboratories - Abstract
Background The COVID-19 pandemic has impacted surveillance activities for multiple pathogens. Since March 2020, there was a decline in the number of reports of norovirus and Campylobacter recorded by England’s national laboratory surveillance system. The aim is to estimate and compare the impact of the COVID-19 pandemic on norovirus and Campylobacter surveillance data in England. Methods We utilised two quasi-experimental approaches based on a generalised linear model for sequential count data. The first approach estimates overall impact and the second approach focuses on the impact of specific elements of the pandemic response (COVID-19 diagnostic testing and control measures). The following time series (27, 2015–43, 2020) were used: weekly laboratory-confirmed norovirus and Campylobacter reports, air temperature, conducted Sars-CoV-2 tests and Index of COVID-19 control measures stringency. Results The period of Sars-CoV-2 emergence and subsequent sustained transmission was associated with persistent reductions in norovirus laboratory reports (p = 0.001), whereas the reductions were more pronounced during pandemic emergence and later recovered for Campylobacter (p = 0.075). The total estimated reduction was 47% - 79% for norovirus (12–43, 2020). The total reduction varied by time for Campylobacter, e.g. 19% - 33% in April, 1% - 7% in August. Conclusion Laboratory reporting of norovirus was more adversely impacted than Campylobacter by the COVID-19 pandemic. This may be partially explained by a comparatively stronger effect of behavioural interventions on norovirus transmission and a relatively greater reduction in norovirus testing capacity. Our study underlines the differential impact a pandemic may have on surveillance of gastrointestinal infectious diseases.
- Published
- 2021